Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Presentations
Prospectus
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
IslandWatch Newsletter
Contact
Contact Us
Subscribe for Email Alerts
Media
Media
>
News
News
IslandWatch Newsletter
News
Filter by Year:
2024
2023
2022
2021
2020
6-Nov-2024
The Australian: Island Pharmaceuticals’ two-pronged plan to put the mozz on dengue fever
15-Oct-2024
The Australian: Pitt Street Research says Island Pharmaceuticals should be worth up to 115% more
15-Oct-2024
Bioshares: Island Pharmaceuticals Shares Surge on Trial Start and Capital Raise
8-Oct-2024
Island Pharmaceuticals Investor Update - October 2024
4-Oct-2024
Island Pharmaceuticals doses subjects in dengue fever trial, enters final phase for 2024 results
3-Oct-2024
The Australian: Island lifts 50pc on $3.5m capital raise and Phase 2a/b dengue trial progress
3-Oct-2024
ausbiz: The small cap itching closer to stopping dengue's spread
3-Oct-2024
VIDEO: Professor Stephen Thomas discusses the challenges and opportunities with dengue research
3-Oct-2024
VIDEO: Island CEO on major milestones: subjects dosed in dengue trial & $3.5M Placement
27-Aug-2024
Stockhead: Island announces US Army IRB approval, commences subject screening for Phase 2a/b trial
1
2
3
Next
.png){kind=logo}
